MENLO PARK, Calif., Jan. 31 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) today announced that Conor Medsystems stockholders approved the merger agreement between Conor...
MENLO PARK, Calif., Jan. 17 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) issued the following comment on the decision by District Court in The Hague which found Conor...
Court Orders Injunction and Damages NATICK, Mass., Jan. 17 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE:BSX) announced today that it and Angiotech Pharmaceuticals, Inc. (Nasdaq:...
Decision Upholds Ruling Invalidating Angiotech Patent on Paclitaxel Coated Stents MENLO PARK, Calif., Jan 16 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) announced that the...
MENLO PARK, Calif., Jan. 9 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) today announced that the U.S. Federal Trade Commission has granted early termination of the waiting...
Conor Medsystems to Complement Cordis' Drug-Eluting Stent Capabilities With Unique Controlled Drug Delivery Technology NEW BRUNSWICK, N.J. and MENLO PARK, Calif., Nov. 16 /PRNewswire-FirstCall/...
MENLO PARK, Calif., Nov. 8 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) today announced results of operations for the quarter ended September 30, 2006. Conor reported a net...
MENLO PARK, Calif., Nov. 2 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) today announced that its third quarter 2006 financial results will be released Wednesday, November 8...
MENLO PARK, Calif., Oct. 5 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR), a developer of innovative, controlled vascular drug delivery technologies, today announced that the...
MENLO PARK, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Conor Medsystems, Inc. (NASDAQ:CONR) is scheduled to present at the A.G. Edwards Emerging Growth Conference on Wednesday, September 20...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約